Arbor Biosciences and TATAA Biocenter Announce Strategic Partnership for NGS and Synthetic Biology Products in Europe Ann Arbor, Michigan and Göteborg, Sweden September 12, 2018 – Arbor Biosciences, a U.S-based company specializing in next generation sequencing (NGS) target enrichment and synthetic biology, announces their partnership with TATAA Biocenter, the world´s foremost organizer of hands-on training [...]

Schauenburg Analytics, parent company of Markes International and SepSolve Analytical, is set to officially open new state-of-the-art laboratories and training facilities in Offenbach am Main, Germany, on 18 September 2018. Both Markes International and SepSolve Analytical are undergoing rapid expansion, with Markes manufacturing instrumentation for thermal desorption and related sampling techniques, while SepSolve specialises in [...]

Simulations Plus, Inc. (Nasdaq: SLP), the leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today announced that it has received notice from the U.S. Food and Drug Administration (FDA) that it has been awarded a new funded cooperative agreement, for $250,000 per year for up to two [...]

PORT WASHINGTON, NY – Pall Corporation, a global leader in filtration, separation and purification, has announced a strategic partnership between its Pall Biotech business unit and Aetos Biologics, a biosimilar cell line development company. The companies will collaborate to offer biosimilar manufacturing solutions to the global biosimilars market. Pall Biotech will provide access to next generation bioprocess equipment, such [...]

Los Angeles, CA – CalibreScientific® is pleased to announce that it has completed the acquisition of PhytoTechnology Laboratories, LLC (“PhytoTech Labs“ or the “Company”), a provider of products for plant molecular biology and plant tissue culture research sold throughout the world. Headquartered in Lenexa, Kansas, PhytoTech Labs is an industry leading provider with a diversified product [...]

Secures and Consolidates Unrestricted Rights for Simoa Technology in Diagnostics Market LEXINGTON, Mass.-- Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced the consolidation of its licensing position and reestablishment of control of its intellectual property in the in vitro diagnostics (IVD) field. The termination of the license [...]

System integrates phenotypic and genomic information at massive scale to define heterogeneity in cell populations, accelerate research, drug discovery and drug development DURHAM, N.C.--Celldom, Inc. today announced that it has been awarded a $1.5 million Phase II Small Business Innovation Research (SBIR) grant by the National Institutes of Health’s National Institute of General Medical Sciences [...]

Proteins are the building blocks of life. They form the structure of cells, regulate cellular activity and carry out the biochemical processes that underpin function in every living organism. To understand proteins and their function, we must understand the way they fold, aggregate and interact. Fluidic Analytics Ltd, Cambridge UK, has announced the global launch [...]

Partnership combines Intellegens’ proprietary AI technology with Optibrium’s expertise in predictive modeling and compound design Optibrium™, a developer of software for drug discovery, announced it had signed a collaboration agreement with Intellegens, a company developing novel artificial intelligence (AI) software. The collaboration will provide Optibrium clients with access to advanced, proprietary deep learning methods that [...]

Cambridge, Mass. and Athens, Greece. Seven Bridges, the leading biomedical data platform and analytics company, and e-NIOS, a biological knowledge discovery start-up, announced a strategic partnership towards data-driven discovery of biomarker signatures. Derivation of robust biomarkers from next generation sequencing and multi-omic data is currently a major bottleneck in precision medicine initiatives. This bottleneck continues to limit [...]